Investor Information Available At:
CanniMed News Banner


Health Canada Approved Volcano Medic Vaporizer used for Medical Marijuana to be Distributed by CanniMed Ltd.

Vaporization ensures dose consistency and minimizes health risks inherent in smoking

SASKATOON, Feb. 26, 2014 /CNW/ - CanniMed Ltd. is excited to announce an agreement with Storz & Bickel GmbH & Co. to be a Canadian distributor of the Volcano® Medic vaporizer, the only device approved by Health Canada for the consumption of medical marijuana. This vaporization system gives CanniMed patients another delivery option to consume medical marijuana without the health concerns inherent in smoking.

With precise temperature controls, the Volcano Medic heats the cannabinoids in marijuana, including Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), just to the point where they become vapor and are inhaled by the patient. Because the temperature does not get high enough for the leaves and other plant matter to burn, patients can be confident that the vapor is the purest, most natural form of marijuana. Additionally, the Volcano Medic mouthpiece features a check valve that reduces the chance for contamination to be left behind.

"The Volcano Medic is a top-of-the-line piece of medical equipment. It's the best vaporizer on the market, bar none," said Brent Zettl, CEO, CanniMed Ltd. "This is the first time the Medic has been available in Canada and we're excited to be able to bring it to our patients."

Using this delivery method for medical marijuana is exceptionally valuable because the vapour produced can be tested to determine the exact cannabinoid dose that is being delivered to the patient, offering a solution to the physicians concerns of dose consistency.

Registered CanniMed patients are now able to order the Volcano Medic from in conjunction with their medical marijuana order.

About CanniMed

CanniMed Ltd. was the first producer to be licensed under the new Marihuana for Medical Purposes Regulations(MMPR). Our pharmaceutical-grade marijuana is produced under Good Manufacturing Practices (GMP) regulations, the criteria used to manufacture all pharmaceuticals in Canada.

Our primary focus is patient safety by strictly following a 281 point quality control process.

SOURCE CanniMed Ltd.

For further information:

CanniMed Ltd.
Phone: 306-975-1207

Dara Willis
Dara Willis Communications
Mobile: 416-836-9272